Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area

By Richie E.E.   Punjabi N.H.N.H.   Sidharta Y.Y.   Peetosutan K.K.   Sukandar M.M.   Wasserman S.S.S.S.   Lesmana M.M.   Wangsasaputra F.F.   Pandam S.S.   Levine M.M.M.M.   O'Hanley P.P.   Cryz S.J.S.J.   Simanjuntak C.H.C.H.  

Vaccine, Vol. 18, Iss. 22, 2000-05 ,pp. : 2399-2410

Elsevier

Access to resources Recommend Favorite

Local and systemic immune responses to combined Vibrio cholerae CVD103-HgR and Salmonella typhi Ty21a live oral vaccines after primary immunization and reimmunization

By Kollaritsch H.   Cryz S.J.   Lang A.B.   Herzog C.   Que J.U.   Wiedermann G.  

Vaccine, Vol. 18, Iss. 26, 2000-07 ,pp. : 3031-3039

Elsevier

Access to resources Recommend Favorite

Further evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humans

By Mao J.S.   Chai S.A.   Xie R.Y.   Chen N.L.   Jiang Q.   Zhu X.Z.   Zhang S.Y.   Huang H.Y.   Mao H.W.   Bao X.N.   Liu C.J.  

Vaccine, Vol. 15, Iss. 9, 1997-06 ,pp. : 944-947

Elsevier

Access to resources Recommend Favorite

guaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin

By Anderson R.J.   Pasetti M.F.   Sztein M.B.   Levine M.M.   Noriega F.R.  

Vaccine, Vol. 18, Iss. 21, 2000-04 ,pp. : 2193-2202

Elsevier

Access to resources Recommend Favorite

Experience with live attenuated varicella vaccine (Oka strain) in healthy Japanese subjects; 10-year survey at pediatric clinic

By Ozaki T.   Nishimura N.   Kajita Y.  

Vaccine, Vol. 18, Iss. 22, 2000-05 ,pp. : 2375-2380

Elsevier

Access to resources Recommend Favorite